Footnotes An agonist is a drug (or other substance) that binds to a specific receptor in the body and turns it on, triggering the same biological response the natural molecule would
Use body-weight trends across weeks, how clothes fit, strength progression, and, when possible, simple body composition checks
Its once-weekly dosing improves patient adherence, while strong clinical outcomes and widespread physician adoption further support its market leadership The type 2 diabetes mellitus is expected to account for the largest share during the forecast period in application market In 2025, the type 2 diabetes mellitus segment is expected to dominate the market with the largest market share of 74.5% due to the widespread adoption of GLP-1 receptor agonists, such as Ozempic and Trulicity, for managing Type 2 diabetes
Description: Epithalon (also known as Epitalon or Epithalamin Analog) is a synthetic tetrapeptide extensively studied for its potential role in cellular aging and telomere biology
Weeks 5-6: Step down to 0.5 mg weekly
